04/22/2024
3:31 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 20-F/A | |
04/17/2024
11:15 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form EFFECT | |
04/17/2024
3:20 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B4 | |
04/16/2024
4:00 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
7:30 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
7:30 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
7:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
|
04/10/2024
7:15 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
04/10/2024
7:15 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
10:03 AM | Altamira Therapeutics Ltd. (Subject)
Altamira Therapeutics (Subject)
Meyer Thomas (Filed by)
| Form SC 13D/A | |
01/22/2024
4:02 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B4 | |
01/21/2024
11:15 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form EFFECT | |
01/19/2024
3:40 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B5 | |
01/19/2024
3:45 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/19/2024
3:30 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/08/2024
4:02 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
12/11/2023
7:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
7:01 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/08/2023
8:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/22/2023
3:30 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023
7:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/31/2023
3:30 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
8:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/12/2023
6:30 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2023
6:31 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K/A | |
07/28/2023
6:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
7:32 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/07/2023
3:14 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B4 | |
07/05/2023
11:15 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form EFFECT | |
06/30/2023
5:30 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2023
3:45 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/16/2023
4:01 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/15/2023
3:30 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/11/2023
11:15 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form EFFECT | |
06/11/2023
11:15 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form EFFECT | |
06/09/2023
3:35 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B3 | |
06/09/2023
3:36 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 424B3 | |
05/30/2023
7:00 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/26/2023
4:29 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
3:30 PM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2023
7:08 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad) Don't Buy Bullion or Mining Stocks. Do THIS Instead
As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea. Click here to find out what to do. |
05/02/2023
7:30 AM | Altamira Therapeutics Ltd. (Filer)
Altamira Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/27/2023
3:30 PM | Altamira Therapeutics Ltd. (Subject)
Altamira Therapeutics (Subject)
Meyer Thomas (Filed by)
| Form SC 13D/A | |
